Inactive Instrument

Allium Medical Solutions Ltd Share Price TEL AVIV STOCK EXCHANGE

Equities

IL0011014508

Medical Equipment, Supplies & Distribution

Financials

Sales 2022 - Sales 2023 - Capitalization 40.22M 10.56M 4.02B 881M
Net income 2022 -12M -3.15M -1.2B -263M Net income 2023 1M 263K 100M 21.9M EV / Sales 2022 -
Net cash position 2022 20.36M 5.35M 2.04B 446M Net cash position 2023 56.23M 14.77M 5.62B 1.23B EV / Sales 2023 -
P/E ratio 2022
-1.78 x
P/E ratio 2023
28.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 64.33%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 68 01/22/01
Director/Board Member 54 01/12/01
Comptroller/Controller/Auditor 38 17/21/17
Members of the board TitleAgeSince
Founder 68 04/04/04
Director/Board Member 54 01/12/01
Director/Board Member 55 03/22/03
More insiders
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
More about the company